In February this year we announced our plans for developing our clinical CRO into a Development CRO. This means that we will be taking responsibility of product development of drugs and medical devices from product candidate selection, through evaluation of efficacy and safety studies, registration, and product launch. We are now well on our way in this process.
With this newsletter we want to update customers and partners on new services as we go along. In addition we will highlight and explore topics of particular interest, e.g. of clinical, regulatory, or operational concern.
In this first issue we can present new services within Medical Affairs, Regulatory Affairs and QA, and Technical Services. We put focus on the concept of aCROnordic Academy which has successfully proven to adapt to unmet needs with our customers. Finally, we now offer services through our own office in Finland.
Read the first issue of aCROnordic News here !